Organoidsciences Ltd. (KOSDAQ:476040)
South Korea
· Delayed Price · Currency is KRW
44,450
+3,650 (8.95%)
At close: Dec 5, 2025
Organoidsciences Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 2,546 | 1,953 | 1,591 | 438.24 |
| Revenue Growth (YoY) | 37.41% | 22.77% | 263.05% | - |
| Cost of Revenue | 46.69 | 42.8 | 44.5 | 26.26 |
| Gross Profit | 2,499 | 1,910 | 1,547 | 411.98 |
| Selling, General & Admin | 10,607 | 8,563 | 6,211 | 4,560 |
| Research & Development | 5,992 | 5,217 | 4,776 | 6,227 |
| Amortization of Goodwill & Intangibles | 64.62 | 55.48 | 25.33 | 13.7 |
| Other Operating Expenses | 1.87 | 32.11 | 44.04 | 38.26 |
| Operating Expenses | 16,978 | 14,145 | 11,341 | 10,965 |
| Operating Income | -14,479 | -12,235 | -9,795 | -10,553 |
| Interest Expense | -352.55 | -3,190 | -5,992 | -4,906 |
| Interest & Investment Income | 200.22 | 481.1 | 924.75 | 582.06 |
| Currency Exchange Gain (Loss) | 34.69 | 19.26 | 18.98 | - |
| Other Non Operating Income (Expenses) | 23.09 | 3,226 | -24,068 | -9,235 |
| EBT Excluding Unusual Items | -14,574 | -11,699 | -38,911 | -24,111 |
| Gain (Loss) on Sale of Investments | 386.02 | 163.05 | 43.05 | - |
| Pretax Income | -14,188 | -11,536 | -38,868 | -24,111 |
| Earnings From Continuing Operations | -14,188 | -11,536 | -38,868 | -24,111 |
| Minority Interest in Earnings | 353.2 | 289.06 | 180.86 | - |
| Net Income | -13,834 | -11,246 | -38,687 | -24,111 |
| Net Income to Common | -13,834 | -11,246 | -38,687 | -24,111 |
| Shares Outstanding (Basic) | 6 | 4 | 3 | 3 |
| Shares Outstanding (Diluted) | 6 | 4 | 3 | 3 |
| Shares Change (YoY) | 58.79% | 45.84% | - | - |
| EPS (Basic) | -2436.28 | -2690.83 | -13499.65 | -8413.46 |
| EPS (Diluted) | -2436.28 | -2690.83 | -13499.65 | -8413.46 |
| Free Cash Flow | -13,590 | -9,808 | -8,196 | -10,304 |
| Free Cash Flow Per Share | -2393.18 | -2346.59 | -2859.93 | -3595.68 |
| Gross Margin | 98.17% | 97.81% | 97.20% | 94.01% |
| Operating Margin | -568.78% | -626.38% | -615.62% | -2407.94% |
| Profit Margin | -543.45% | -575.78% | -2431.56% | -5501.84% |
| Free Cash Flow Margin | -533.84% | -502.11% | -515.13% | -2351.33% |
| EBITDA | -13,107 | -10,931 | -8,651 | -9,748 |
| D&A For EBITDA | 1,372 | 1,304 | 1,144 | 804.46 |
| EBIT | -14,479 | -12,235 | -9,795 | -10,553 |
| Advertising Expenses | - | 332.07 | 139.83 | 145.37 |
Source: S&P Capital IQ. Standard template.
Financial Sources.